Literature DB >> 22902230

Chemical and biological assessment of Angelica herbal decoction: comparison of different preparations during historical applications.

Wendy Li Zhang1, Ken Yu-Zhong Zheng, Kevin Yue Zhu, Janis Ya-Xian Zhan, Cathy Wen-Chuan Bi, Jian-Ping Chen, Crystal Ying-Qing Du, Kui-Jun Zhao, David Tai-Wai Lau, Tina Ting-Xia Dong, Karl Wah-Keung Tsim.   

Abstract

The commonly used Angelica herbal decoction today is Danggui Buxue Tang (DBT), which is a dietary supplement in treating menopausal irregularity in women, i.e. to nourish "Qi" and to enrich "Blood". According to historical record, many herbal decoctions were also named DBT, but the most popular formulation of DBT was written in Jin dynasty (1247 AD) of China, which contained Astragali Radix (AR) and Angelicae Sinensis Radix (ASR) with a weight ratio of 5:1. However, at least two other Angelica herbal decoctions recorded as DBT were prescribed in Song (1155 AD) and Qing dynasties (1687 AD). Although AR and ASR are still the major components in the DBT herbal decoctions, they are slightly varied in the herb composition. In order to reveal the efficiency of different Angelica herbal decoctions, the chemical and biological properties of three DBT herbal extracts were compared. Significantly, the highest amounts of AR-derived astragaloside III, astragaloside IV, calycosin and formononetin and ASR-derived ferulic acid were found in DBT described in 1247 AD: this preparation showed stronger activities in osteogenic, estrogenic and erythropoetic effects than the other two DBT. The current results supported the difference of three DBT in chemical and biological properties, which could be a result of different herbal combinations. For the first time, this study supports the popularity of DBT described in 1247 AD.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902230     DOI: 10.1016/j.phymed.2012.07.009

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  12 in total

1.  A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo.

Authors:  Tao Guo; Zu-Long Liu; Qiang Zhao; Zhi-Min Zhao; Cheng-Hai Liu
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

Review 2.  The Latest Research Advances of Danggui Buxue Tang as an Effective Prescription for Various Diseases: A Comprehensive Review.

Authors:  Chen-Chen Ma; Yue-Hua Jiang; Yan Wang; Rui-Rong Xu
Journal:  Curr Med Sci       Date:  2022-10-17

Review 3.  Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus.

Authors:  Guowei Gong; Yuzhong Zheng; Yang Yang; Yixuan Sui; Zhen Wen
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-06       Impact factor: 2.629

4.  Calycosin Orchestrates Osteogenesis of Danggui Buxue Tang in Cultured Osteoblasts: Evaluating the Mechanism of Action by Omics and Chemical Knock-out Methodologies.

Authors:  Amy G W Gong; Ran Duan; Huai Y Wang; Tina T X Dong; Karl W K Tsim
Journal:  Front Pharmacol       Date:  2018-02-01       Impact factor: 5.810

5.  Chemical and biological assessment of angelica roots from different cultivated regions in a chinese herbal decoction danggui buxue tang.

Authors:  Wendy L Zhang; Ken Y Z Zheng; Kevin Y Zhu; Janis Y X Zhan; Cathy W C Bi; J P Chen; Tina T X Dong; Roy C Y Choi; David T W Lau; Karl W K Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-05       Impact factor: 2.629

6.  Quality Control of Danggui Buxue Tang, a Traditional Chinese Medicine Decoction, by (1)H-NMR Metabolic Profiling.

Authors:  Pui Hei Chan; Wendy L Zhang; Chi Yuen Cheung; Karl W K Tsim; Henry Lam
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-23       Impact factor: 2.629

7.  Hydrolysis of Glycosidic Flavonoids during the Preparation of Danggui Buxue Tang: An Outcome of Moderate Boiling of Chinese Herbal Mixture.

Authors:  Wendy Li Zhang; Jian-Ping Chen; Kelly Yin-Ching Lam; Janis Ya-Xian Zhan; Ping Yao; Tina Ting-Xia Dong; Karl Wah-Keung Tsim
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-16       Impact factor: 2.629

8.  Comparison of ferulic acid content in Radix Angelicae Sinensis, Danggui-Buxue-Tang and Danggui-Sini-Tang.

Authors:  Jia-Mei Yao; Li-Jin Yu; Qiong Chen; Ze-Qi Chen; Dong-Sheng Wang; Xin-Jian Qiu; Lin-Lin Zhao
Journal:  Exp Ther Med       Date:  2014-02-14       Impact factor: 2.447

9.  Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling.

Authors:  Youn Kyung Choi; Sung-Gook Cho; Sang-Mi Woo; Yee Jin Yun; Sunju Park; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2014-05-25       Impact factor: 4.711

10.  SH003 reverses drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer cells.

Authors:  Hye-Sook Seo; Jin Mo Ku; Hee-Jae Lee; Jong-Kyu Woo; Chunhoo Cheon; Mia Kim; Bo-Hyoung Jang; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Biosci Rep       Date:  2017-11-15       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.